Cell Culture – News and Features

A new type of off-the-shelf cell-based immunotherapy shows promise for B-cell lymphomas, and could make make future cellular immunotherapies less expensive and more accessible.

Technology Networks spoke with Dr. Thomas Dennison, University of Cambridge, to learn more about the advantages of using patient-derived organoids for modeling inflammatory bowel disease (IBD).

Researchers have developed a new strategy to enhance pharmaceutical production in Chinese hamster ovary (CHO) cells, which are commonly used to manufacture protein-based drugs for treating cancer, autoimmune diseases and much more.

A new look at cancer cells: Würzburg researchers show how therapeutic antibodies work – thanks to an innovative method of super-resolution microscopy.

A new AI tool can accurately predict gene activity within any human cell, revealing the cell's inner mechanisms.

The injection of heart muscle spheroids derived from hiPSCs can aid heart attack recovery in animal models.

ECRC researchers developed a CRISPR-based gene therapy targeting dysferlin mutations in muscular dystrophy. By editing and transplanting corrected muscle stem cells, they restored protein function and regrew muscle in preclinical models.

UC researchers reveal that miR-205 regulates MED1 and HER3, proteins driving breast cancer treatment resistance. Boosting miR-205 levels could block MED1 production and activity, enhancing therapy outcomes.

Researchers have discovered that weak molecular interactions are crucial for initiating autophagy, the process of recycling cellular waste. Using yeast cells, they demonstrated that weak receptor binding triggers this process.

Researchers at Ruhr University Bochum discovered that a lipid anchor on nerve cell membranes stabilizes prion protein folding, preventing harmful aggregation linked to prion diseases.